Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 161 citing KARP: Oral norfloxacin for prevention of gram-negative bacterial infections in patients with.... (0.11 sec) 

From the Infectious Disease Society of America: guidelines for the use of antimicrobial …


WT Hughes, D Armstrong, GP Bodey, R Feld, … - The Journal of Infectious Diseases, 1990 - jstor.org
This is one in a series of reports by the Infectious Diseases Society of America
to address issues in antimicrobial ther- apy. The neutropenic patient who
becomes febrile has a >60 % likelihood of being infected. If the neutrophil ...
Cited by 1146 - Related articles - All 3 versions

Management of fever in patients with cancer and treatment-induced neutropenia


PA Pizzo - The New England journal of medicine, 1993 - nejm.highwire.org
The importance of neutropenia in the risk of serious infection in patients with
cancer who are receiving cytotoxic chemotherapy was first recognized nearly 30
years ago 1 . Since then, considerable progress has been made in the ...
Cited by 635 - Related articles - BL Direct - All 5 versions

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a …


P Ginés, A Rimola, R Planas, V Vargas, F … - Hepatology, 1990 - interscience.wiley.com
Eighty cirrhotic patients who had recovered from an episode of spontaneous
bacterial peritonitis were included in a multicenter, double-blind trial aimed
at comparing long-term norfloxacin administration (400 mg/day; 40 patients) ...
Cited by 288 - Related articles - All 2 versions

Bacteremia due to viridans streptococci in neutropenic patients: a review


PY Bochud, T Calandra, P Francioli - The American journal of medicine, 1994 - Elsevier
Viridans streptococci have long been considered, with the exception of the
ability to cause endocarditis, as minor pathogenic agents. More recently,
however, these bacteria have become a major concern in neutropenic patients ...
Cited by 219 - Related articles - All 4 versions

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta- …


M Cruciani, R Rampazzo, M Malena, L … - Clinical Infectious Diseases, 1996 - jstor.org
We conducted a two-part meta-analysis to assess the effectiveness of
fluoroquinolones for pre- venting bacterial infections in granulocytopenic
patients who are receiving chemotherapy for malig- nancies. Overall, 19 ...
Cited by 182 - Related articles - BL Direct - All 5 versions

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

- jcojournal.org [PDF] 
EA Engels, J Lau, M Barza - Journal of Clinical Oncology, 1998 - jcojournal.org
Purpose: To perform a meta-analysis to estimate the efficacy of quinolone
antibiotics in preventing infec- tions, fevers, and deaths among cancer patients
neutro- penic following chemotherapy. Methods: We searched MEDLINE to ...
Cited by 158 - Related articles - All 6 versions

Phase I and pharmacodynamic study of taxol in refractory acute leukemias

- aacrjournals.org [PDF] 
EK Rowinsky, PJ Burke, JE Karp, RW Tucker, … - Cancer Research, 1989 - AACR
Taxol, a novel antimicrotubule agent that enhances tubulin polymeri zation and
microtubule stability, was administered to adults with refrac tory leukemias as
a 24-h iv infusion in a Phase I study. The primary objectives were to ...
Cited by 148 - Related articles - All 5 versions

[CITATION] Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia


A Cometta, T Calandra, J Bille, MP Glauser - New England Journal of Medicine, 1994 - content.nejm.org
All 92 strains of E. coli isolated from blood specimens between 1983 and 1990
were susceptible to the five quinolones tested -- ciprofloxacin, norfloxacin,
ofloxacin, levofloxacin, and sparfloxacin (minimal inhibitory ...
Cited by 141 - Related articles - All 5 versions

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with …


J Carratalá, A Fernández-Sevilla, F Tubau, M … - Clinical infectious diseases, 1995 - jstor.org
Between January 1988 and December 1992, 35 episodes of Escherichia coli
bacteremia were identified in a series of 230 cases of bacteremia in neutropenic
patients with cancer. Thirteen episodes (37%) were due to ...
Cited by 126 - Related articles - BL Direct - All 5 versions

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia

- stmarysresident.org [PDF] 
G Bucaneve, A Micozzi, F Menichetti, P Martino … - The New England journal of medicine, 2005 - nejm.highwire.org
From Policlinico Monteluce, Perugia (GB, MSD, ADF); Università La Sapienza,
Rome (AM, PM, RF); Ospedale Cisanel- lo, Pisa (FM); Istituto Oncologico Euro-
peo, Milan (GM); Ospedale Santi Anto- nio e Biagio, Alessandria (BA); ...
Cited by 119 - Related articles - BL Direct - All 12 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google